Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04685551

Improving Survivorship Among Minority Cancer Dyads

Improving Survivorship Outcomes for African American and Latinx Cancer Survivors and Caregiver Dyads Through A Culturally Based Training Program for Underserved Health Professional Students

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Charles Drew University of Medicine and Science · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This proposed intervention centers on improving survivorship outcomes among African American and Latinx cancer survivor and caregiver dyads. As a result, there will be four major outcomes. First, as a result of partnership with minority social institutions (e.g. faith leaders), we will develop an in-depth culturally sensitive curriculum and survivorship care plan for Cancer Survivorship and Caregiver Leaders Aimed for Minority Populations (CSC LAMPs). Second, we will increase knowledge and skills by evaluating a comprehensive cancer survivorship training program designed for underserved health professional students. Third, the implementation of this program will improve survivorship outcomes among African American and Latinx cancer survivors with advanced stage cancer and their caregivers. Lastly, this study will build sustainability for underserved minorities with the training of 30 future healthcare providers as a valuable community resource for improving cancer survivorship outcomes. The long-term outcomes of the CSC LAMPs program will generate workforce capacity and diversity in cancer-based clinical practice, research, and community advocacy for underserved minority cancer survivors and caregivers.

Conditions

Interventions

TypeNameDescription
BEHAVIORALChange in knowledge, motivation, skills, and resourcesProvide/enhance knowledge, modify attitudes, motivate and provide skills and resources to improve survivorship outcomes.

Timeline

Start date
2021-07-01
Primary completion
2024-06-30
Completion
2024-12-31
First posted
2020-12-28
Last updated
2022-07-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04685551. Inclusion in this directory is not an endorsement.